Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways
Renal interstitial fibrosis (RIF) is characterized by the accumulation of inflammatory cytokines and epithelial-mesenchymal transition (EMT). Curcumin exerts antifibrogenic, anti-inflammatory and antiproliferative effects. To explore the mechanisms underlying the effects of curcumin on RIF. Eight-we...
Gespeichert in:
Veröffentlicht in: | Pharmaceutical biology 2020-01, Vol.58 (1), p.828-837 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 837 |
---|---|
container_issue | 1 |
container_start_page | 828 |
container_title | Pharmaceutical biology |
container_volume | 58 |
creator | Wang, Zhaohui Chen, Zhi Li, Bingsheng Zhang, Bo Du, Yongchao Liu, Yuhang He, Yao Chen, Xiang |
description | Renal interstitial fibrosis (RIF) is characterized by the accumulation of inflammatory cytokines and epithelial-mesenchymal transition (EMT). Curcumin exerts antifibrogenic, anti-inflammatory and antiproliferative effects.
To explore the mechanisms underlying the effects of curcumin on RIF.
Eight-week-old male C57BL/6 mice were intragastrically administered curcumin (50 mg/kg/day) for 14 days after undergoing unilateral ureteral obstruction (UUO) operations. Renal function (blood urea nitrogen [BUN] and serum creatinine [Scr]) and inflammatory cytokine levels were tested using colorimetric assays and ELISA, respectively. EMT markers were evaluated through immunohistochemistry, western blotting and qPCR. Transforming growth factor beta 1 (TGF-β1; 10 ng/mL) and lipopolysaccharides (LPS; 100 ng/mL) were used to stimulate EMT and an inflammatory response in human renal proximal tubular epithelial (HK-2) cells, respectively, for further investigation.
In vivo, curcumin significantly improved the levels of BUN and Scr by 28.7% and 21.3%, respectively. Moreover, curcumin reduced the levels of IL-6, IL-1β and TNF-α by 22.5%, 30.3% and 26.7%, respectively, and suppressed vimentin expression in UUO mice. In vitro, curcumin reduced the expression of vimentin and α-smooth muscle actin in TGF-β1-induced HK-2 cells. In LPS-induced HK-2 cells, curcumin decreased the release of IL-6, IL-1β and TNF-α by 43.4%, 38.1% and 28.3%, respectively. In addition, curcumin reduced the expression of TLR4, p-PI3K, p-AKT, p-NF- κB and p-IκBα in both LPS- and TGF-β1-induced HK-2 cells.
Curcumin repressed EMT and the inflammatory response by inhibiting the TLR4/NF-κB and PI3K/AKT pathways, demonstrating its potential utility in RIF treatment. |
doi_str_mv | 10.1080/13880209.2020.1809462 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7470153</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_dc779ebd2b9e4db4bfde2914d79c9348</doaj_id><sourcerecordid>2509433348</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4542-98a3fa11f31342df5d714e03d7aca21b783b6018dfe40b856efbf60ba52679a83</originalsourceid><addsrcrecordid>eNp9ks1u1DAUhSMEomXgEZAssWGT1o6dvw2iHVEYdQQIlbVlx9cTjxI72E6rvBpLnoBHwsMUpLJg499zPl_5nix7SfAZwQ0-J7RpcIHbsyKNZ6TBLauKR9kpqRnLS0Kqx2mdNPlBdJI9C2GPMS4pLZ9mJ7RoqgqX7Wn2Yz37bh6NRSJGsLOIEJAHKwZkbAQfookmbbSR3gUTkNPIyRD93EVzC8jC1Hs3idgvSC4ozNPkIQRjdwgmE3sYkjsfIYDt-mVMpOiFDQnqLIrJOu_69FJv5PEo4ZMJ3Wy_sPOPV_nP75dIWIU-b-j1-cX1DQpml2obDvzDo3diCc-zJ1oMAV7cz6vs69W7m_WHfPvp_WZ9sc07VrIibxtBtSBEU0JZoXSpasIAU1WLThRE1g2VFSaN0sCwbMoKtNQVlqIsqroVDV1lmyNXObHnkzej8At3wvDfB87vuPDRdANw1dV1C1IVsgWmJJNaQdESpuq2ayk7sN4cWdMsR1Ad2PQtwwPowxtrer5zt7xmNSapi6vs9T3Au28zhMhHEzoYBmHBzYEXjLYVLWtSJOmrf6R7N_v0i0lVpthQeqyoPKq61OfgQf8thmB-SBz_kzh-SBy_T1zyvT36jNXOj-LO-UHxKJbBeZ1a3ZnA6f8RvwCCo-Hq</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2509433348</pqid></control><display><type>article</type><title>Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways</title><source>Taylor & Francis Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wang, Zhaohui ; Chen, Zhi ; Li, Bingsheng ; Zhang, Bo ; Du, Yongchao ; Liu, Yuhang ; He, Yao ; Chen, Xiang</creator><creatorcontrib>Wang, Zhaohui ; Chen, Zhi ; Li, Bingsheng ; Zhang, Bo ; Du, Yongchao ; Liu, Yuhang ; He, Yao ; Chen, Xiang</creatorcontrib><description>Renal interstitial fibrosis (RIF) is characterized by the accumulation of inflammatory cytokines and epithelial-mesenchymal transition (EMT). Curcumin exerts antifibrogenic, anti-inflammatory and antiproliferative effects.
To explore the mechanisms underlying the effects of curcumin on RIF.
Eight-week-old male C57BL/6 mice were intragastrically administered curcumin (50 mg/kg/day) for 14 days after undergoing unilateral ureteral obstruction (UUO) operations. Renal function (blood urea nitrogen [BUN] and serum creatinine [Scr]) and inflammatory cytokine levels were tested using colorimetric assays and ELISA, respectively. EMT markers were evaluated through immunohistochemistry, western blotting and qPCR. Transforming growth factor beta 1 (TGF-β1; 10 ng/mL) and lipopolysaccharides (LPS; 100 ng/mL) were used to stimulate EMT and an inflammatory response in human renal proximal tubular epithelial (HK-2) cells, respectively, for further investigation.
In vivo, curcumin significantly improved the levels of BUN and Scr by 28.7% and 21.3%, respectively. Moreover, curcumin reduced the levels of IL-6, IL-1β and TNF-α by 22.5%, 30.3% and 26.7%, respectively, and suppressed vimentin expression in UUO mice. In vitro, curcumin reduced the expression of vimentin and α-smooth muscle actin in TGF-β1-induced HK-2 cells. In LPS-induced HK-2 cells, curcumin decreased the release of IL-6, IL-1β and TNF-α by 43.4%, 38.1% and 28.3%, respectively. In addition, curcumin reduced the expression of TLR4, p-PI3K, p-AKT, p-NF- κB and p-IκBα in both LPS- and TGF-β1-induced HK-2 cells.
Curcumin repressed EMT and the inflammatory response by inhibiting the TLR4/NF-κB and PI3K/AKT pathways, demonstrating its potential utility in RIF treatment.</description><identifier>ISSN: 1388-0209</identifier><identifier>EISSN: 1744-5116</identifier><identifier>DOI: 10.1080/13880209.2020.1809462</identifier><identifier>PMID: 32866059</identifier><language>eng</language><publisher>Abingdon: Taylor & Francis</publisher><subject>1-Phosphatidylinositol 3-kinase ; Actin ; AKT protein ; Colorimetry ; Creatinine ; Curcumin ; Enzyme-linked immunosorbent assay ; Fibrosis ; Immunohistochemistry ; Inflammation ; Interleukin 6 ; Lipopolysaccharides ; Mesenchyme ; Nephropathy ; NF-κB protein ; Renal function ; Signal transduction ; Smooth muscle ; TLR4 protein ; Toll-like receptors ; transforming growth factor beta 1 ; Transforming growth factor-b1 ; Tumor necrosis factor-α ; unilateral ureteral obstruction ; Urea ; Vimentin ; Western blotting</subject><ispartof>Pharmaceutical biology, 2020-01, Vol.58 (1), p.828-837</ispartof><rights>2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020</rights><rights>2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4542-98a3fa11f31342df5d714e03d7aca21b783b6018dfe40b856efbf60ba52679a83</citedby><cites>FETCH-LOGICAL-c4542-98a3fa11f31342df5d714e03d7aca21b783b6018dfe40b856efbf60ba52679a83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470153/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470153/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,27479,27901,27902,53766,53768,59116,59117</link.rule.ids></links><search><creatorcontrib>Wang, Zhaohui</creatorcontrib><creatorcontrib>Chen, Zhi</creatorcontrib><creatorcontrib>Li, Bingsheng</creatorcontrib><creatorcontrib>Zhang, Bo</creatorcontrib><creatorcontrib>Du, Yongchao</creatorcontrib><creatorcontrib>Liu, Yuhang</creatorcontrib><creatorcontrib>He, Yao</creatorcontrib><creatorcontrib>Chen, Xiang</creatorcontrib><title>Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways</title><title>Pharmaceutical biology</title><description>Renal interstitial fibrosis (RIF) is characterized by the accumulation of inflammatory cytokines and epithelial-mesenchymal transition (EMT). Curcumin exerts antifibrogenic, anti-inflammatory and antiproliferative effects.
To explore the mechanisms underlying the effects of curcumin on RIF.
Eight-week-old male C57BL/6 mice were intragastrically administered curcumin (50 mg/kg/day) for 14 days after undergoing unilateral ureteral obstruction (UUO) operations. Renal function (blood urea nitrogen [BUN] and serum creatinine [Scr]) and inflammatory cytokine levels were tested using colorimetric assays and ELISA, respectively. EMT markers were evaluated through immunohistochemistry, western blotting and qPCR. Transforming growth factor beta 1 (TGF-β1; 10 ng/mL) and lipopolysaccharides (LPS; 100 ng/mL) were used to stimulate EMT and an inflammatory response in human renal proximal tubular epithelial (HK-2) cells, respectively, for further investigation.
In vivo, curcumin significantly improved the levels of BUN and Scr by 28.7% and 21.3%, respectively. Moreover, curcumin reduced the levels of IL-6, IL-1β and TNF-α by 22.5%, 30.3% and 26.7%, respectively, and suppressed vimentin expression in UUO mice. In vitro, curcumin reduced the expression of vimentin and α-smooth muscle actin in TGF-β1-induced HK-2 cells. In LPS-induced HK-2 cells, curcumin decreased the release of IL-6, IL-1β and TNF-α by 43.4%, 38.1% and 28.3%, respectively. In addition, curcumin reduced the expression of TLR4, p-PI3K, p-AKT, p-NF- κB and p-IκBα in both LPS- and TGF-β1-induced HK-2 cells.
Curcumin repressed EMT and the inflammatory response by inhibiting the TLR4/NF-κB and PI3K/AKT pathways, demonstrating its potential utility in RIF treatment.</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>Actin</subject><subject>AKT protein</subject><subject>Colorimetry</subject><subject>Creatinine</subject><subject>Curcumin</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Fibrosis</subject><subject>Immunohistochemistry</subject><subject>Inflammation</subject><subject>Interleukin 6</subject><subject>Lipopolysaccharides</subject><subject>Mesenchyme</subject><subject>Nephropathy</subject><subject>NF-κB protein</subject><subject>Renal function</subject><subject>Signal transduction</subject><subject>Smooth muscle</subject><subject>TLR4 protein</subject><subject>Toll-like receptors</subject><subject>transforming growth factor beta 1</subject><subject>Transforming growth factor-b1</subject><subject>Tumor necrosis factor-α</subject><subject>unilateral ureteral obstruction</subject><subject>Urea</subject><subject>Vimentin</subject><subject>Western blotting</subject><issn>1388-0209</issn><issn>1744-5116</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks1u1DAUhSMEomXgEZAssWGT1o6dvw2iHVEYdQQIlbVlx9cTjxI72E6rvBpLnoBHwsMUpLJg499zPl_5nix7SfAZwQ0-J7RpcIHbsyKNZ6TBLauKR9kpqRnLS0Kqx2mdNPlBdJI9C2GPMS4pLZ9mJ7RoqgqX7Wn2Yz37bh6NRSJGsLOIEJAHKwZkbAQfookmbbSR3gUTkNPIyRD93EVzC8jC1Hs3idgvSC4ozNPkIQRjdwgmE3sYkjsfIYDt-mVMpOiFDQnqLIrJOu_69FJv5PEo4ZMJ3Wy_sPOPV_nP75dIWIU-b-j1-cX1DQpml2obDvzDo3diCc-zJ1oMAV7cz6vs69W7m_WHfPvp_WZ9sc07VrIibxtBtSBEU0JZoXSpasIAU1WLThRE1g2VFSaN0sCwbMoKtNQVlqIsqroVDV1lmyNXObHnkzej8At3wvDfB87vuPDRdANw1dV1C1IVsgWmJJNaQdESpuq2ayk7sN4cWdMsR1Ad2PQtwwPowxtrer5zt7xmNSapi6vs9T3Au28zhMhHEzoYBmHBzYEXjLYVLWtSJOmrf6R7N_v0i0lVpthQeqyoPKq61OfgQf8thmB-SBz_kzh-SBy_T1zyvT36jNXOj-LO-UHxKJbBeZ1a3ZnA6f8RvwCCo-Hq</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Wang, Zhaohui</creator><creator>Chen, Zhi</creator><creator>Li, Bingsheng</creator><creator>Zhang, Bo</creator><creator>Du, Yongchao</creator><creator>Liu, Yuhang</creator><creator>He, Yao</creator><creator>Chen, Xiang</creator><general>Taylor & Francis</general><general>Taylor & Francis Ltd</general><general>Taylor & Francis Group</general><scope>0YH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200101</creationdate><title>Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways</title><author>Wang, Zhaohui ; Chen, Zhi ; Li, Bingsheng ; Zhang, Bo ; Du, Yongchao ; Liu, Yuhang ; He, Yao ; Chen, Xiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4542-98a3fa11f31342df5d714e03d7aca21b783b6018dfe40b856efbf60ba52679a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>Actin</topic><topic>AKT protein</topic><topic>Colorimetry</topic><topic>Creatinine</topic><topic>Curcumin</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Fibrosis</topic><topic>Immunohistochemistry</topic><topic>Inflammation</topic><topic>Interleukin 6</topic><topic>Lipopolysaccharides</topic><topic>Mesenchyme</topic><topic>Nephropathy</topic><topic>NF-κB protein</topic><topic>Renal function</topic><topic>Signal transduction</topic><topic>Smooth muscle</topic><topic>TLR4 protein</topic><topic>Toll-like receptors</topic><topic>transforming growth factor beta 1</topic><topic>Transforming growth factor-b1</topic><topic>Tumor necrosis factor-α</topic><topic>unilateral ureteral obstruction</topic><topic>Urea</topic><topic>Vimentin</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Zhaohui</creatorcontrib><creatorcontrib>Chen, Zhi</creatorcontrib><creatorcontrib>Li, Bingsheng</creatorcontrib><creatorcontrib>Zhang, Bo</creatorcontrib><creatorcontrib>Du, Yongchao</creatorcontrib><creatorcontrib>Liu, Yuhang</creatorcontrib><creatorcontrib>He, Yao</creatorcontrib><creatorcontrib>Chen, Xiang</creatorcontrib><collection>Taylor & Francis Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pharmaceutical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Zhaohui</au><au>Chen, Zhi</au><au>Li, Bingsheng</au><au>Zhang, Bo</au><au>Du, Yongchao</au><au>Liu, Yuhang</au><au>He, Yao</au><au>Chen, Xiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways</atitle><jtitle>Pharmaceutical biology</jtitle><date>2020-01-01</date><risdate>2020</risdate><volume>58</volume><issue>1</issue><spage>828</spage><epage>837</epage><pages>828-837</pages><issn>1388-0209</issn><eissn>1744-5116</eissn><abstract>Renal interstitial fibrosis (RIF) is characterized by the accumulation of inflammatory cytokines and epithelial-mesenchymal transition (EMT). Curcumin exerts antifibrogenic, anti-inflammatory and antiproliferative effects.
To explore the mechanisms underlying the effects of curcumin on RIF.
Eight-week-old male C57BL/6 mice were intragastrically administered curcumin (50 mg/kg/day) for 14 days after undergoing unilateral ureteral obstruction (UUO) operations. Renal function (blood urea nitrogen [BUN] and serum creatinine [Scr]) and inflammatory cytokine levels were tested using colorimetric assays and ELISA, respectively. EMT markers were evaluated through immunohistochemistry, western blotting and qPCR. Transforming growth factor beta 1 (TGF-β1; 10 ng/mL) and lipopolysaccharides (LPS; 100 ng/mL) were used to stimulate EMT and an inflammatory response in human renal proximal tubular epithelial (HK-2) cells, respectively, for further investigation.
In vivo, curcumin significantly improved the levels of BUN and Scr by 28.7% and 21.3%, respectively. Moreover, curcumin reduced the levels of IL-6, IL-1β and TNF-α by 22.5%, 30.3% and 26.7%, respectively, and suppressed vimentin expression in UUO mice. In vitro, curcumin reduced the expression of vimentin and α-smooth muscle actin in TGF-β1-induced HK-2 cells. In LPS-induced HK-2 cells, curcumin decreased the release of IL-6, IL-1β and TNF-α by 43.4%, 38.1% and 28.3%, respectively. In addition, curcumin reduced the expression of TLR4, p-PI3K, p-AKT, p-NF- κB and p-IκBα in both LPS- and TGF-β1-induced HK-2 cells.
Curcumin repressed EMT and the inflammatory response by inhibiting the TLR4/NF-κB and PI3K/AKT pathways, demonstrating its potential utility in RIF treatment.</abstract><cop>Abingdon</cop><pub>Taylor & Francis</pub><pmid>32866059</pmid><doi>10.1080/13880209.2020.1809462</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1388-0209 |
ispartof | Pharmaceutical biology, 2020-01, Vol.58 (1), p.828-837 |
issn | 1388-0209 1744-5116 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7470153 |
source | Taylor & Francis Open Access; DOAJ Directory of Open Access Journals; PubMed Central; Alma/SFX Local Collection |
subjects | 1-Phosphatidylinositol 3-kinase Actin AKT protein Colorimetry Creatinine Curcumin Enzyme-linked immunosorbent assay Fibrosis Immunohistochemistry Inflammation Interleukin 6 Lipopolysaccharides Mesenchyme Nephropathy NF-κB protein Renal function Signal transduction Smooth muscle TLR4 protein Toll-like receptors transforming growth factor beta 1 Transforming growth factor-b1 Tumor necrosis factor-α unilateral ureteral obstruction Urea Vimentin Western blotting |
title | Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T07%3A09%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Curcumin%20attenuates%20renal%20interstitial%20fibrosis%20of%20obstructive%20nephropathy%20by%20suppressing%20epithelial-mesenchymal%20transition%20through%20inhibition%20of%20the%20TLR4/NF-%D0%BAB%20and%20PI3K/AKT%20signalling%20pathways&rft.jtitle=Pharmaceutical%20biology&rft.au=Wang,%20Zhaohui&rft.date=2020-01-01&rft.volume=58&rft.issue=1&rft.spage=828&rft.epage=837&rft.pages=828-837&rft.issn=1388-0209&rft.eissn=1744-5116&rft_id=info:doi/10.1080/13880209.2020.1809462&rft_dat=%3Cproquest_pubme%3E2509433348%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2509433348&rft_id=info:pmid/32866059&rft_doaj_id=oai_doaj_org_article_dc779ebd2b9e4db4bfde2914d79c9348&rfr_iscdi=true |